3 recruiting, 2 not yet recruiting. 3 Phase 1, 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Not yet recruiting 2, Recruiting 1 |
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 3 | 2 | Recruiting 2 |
Follow SCTB35 injection: new trials by email Literature Review of SCTB35 injection trials Research Report on SCTB35 injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SCTB35 and SCTB41 With or Without Chemotherapy in Non-Hodgkin Lymphoma SCTB35 injection, SCTB41 - NHL - Non-Hodgkin's Lymphoma | Phase 1 / Phase 2 | Not yet recruiting | Sinocelltech Ltd. | 90 | 2026-09-30 | 2026-09-14 |
| A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma SCTB35 injection, Rituximab, Lenalidomide - Follicular Lymphoma (FL) | Phase 3 | Recruiting | Sinocelltech Ltd. | 93 | 2026-06-09 | 2026-08-13 |
| A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma SCTB35 injection, Rituxumab, Gemcitabine - DLBCL - Diffuse Large B Cell Lymphoma | Phase 3 | Recruiting | Sinocelltech Ltd. | 101 | 2026-06-04 | 2026-08-13 |
| A Study of SCTB35 in Patients with Systemic Lupus Erythematosus SCTB35 injection - System Lupus Erythematosus | Phase 1 / Phase 2 | Recruiting | Sinocelltech Ltd. | 168 | 2025-02-01 | 2025-02-21 |
| A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma SCTB35 injection - Non-Hodgkin Lymphoma, B-cell | Phase 1 | Not yet recruiting | Sinocelltech Ltd. | 76 | 2024-04-01 | 2024-03-22 |
Lymphoma, Non-Hodgkin (2) · Dendritic Cell Sarcoma, Interdigitating (1) · Lupus Erythematosus, Systemic (1) · Lymphoma, Follicular (1)
China (5)
Yuqin Song, M.D. (1)